Myocardial infarction type 2 and myocardial injury: The current state of the problem
- Authors: Oblavatskiy D.V.1, Boldueva S.A.1, Solovyeva M.V.1
-
Affiliations:
- North-Western State Medical University named after I.I. Mechnikov
- Issue: Vol 13, No 1 (2021)
- Pages: 5-13
- Section: Reviews
- URL: https://journals.rcsi.science/vszgmu/article/view/59717
- DOI: https://doi.org/10.17816/mechnikov59717
- ID: 59717
Cite item
Abstract
Today, the most difficult in terms of diagnosis and treatment today among various types of myocardial infarction (MI) is MI type 2 (MI-2). The lack of clinical guidelines for management of patients with this type of MI, as well as the literature data on prevalence, patient characteristics and prognosis contributes to the scientific relevance of the further research.
Full Text
##article.viewOnOriginalSite##About the authors
Dmitriy V. Oblavatskiy
North-Western State Medical University named after I.I. Mechnikov
Author for correspondence.
Email: dimi1987@yandex.ru
ORCID iD: 0000-0003-1628-0193
MD
Russian Federation, 47 Piskarevsky Ave., Saint Petersburg, 195067Svetlana A. Boldueva
North-Western State Medical University named after I.I. Mechnikov
Email: svetlanaboldueva@mail.ru
ORCID iD: 0000-0002-1898-084X
SPIN-code: 3716-3375
MD, Professor
Russian Federation, 47 Piskarevsky Ave., Saint Petersburg, 195067Mariya V. Solovyeva
North-Western State Medical University named after I.I. Mechnikov
Email: morethantea@rambler.ru
ORCID iD: 0000-0002-3335-4986
SPIN-code: 2086-5811
MD
Russian Federation, 47 Piskarevsky Ave., Saint Petersburg, 195067References
- Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525–2538. doi: 10.1093/eurheartj/ehm355
- Sandoval Y, Thygesen K. Myocardial infarction type 2 and myocardial injury. Clin Chem. 2017;63(1):101–107. doi: 10.1373/clinchem.2016.255521
- Zhelnov VV, Dyatlov NV, Dvoretskiy LI. Myocardial infarction type 2: myth or reality? Arkhiv vnutrenney meditsiny. 2016;6(2(28)):34–41. doi: 10.20514/2226-6704-2016-6-2-34-41
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction. Russian Journal of Cardiology. 2019;24(3):107–138. doi: 10.15829/1560-4071-2019-3-107-138
- Mihatov N, Januzzi JL Jr, Gaggin HK. Type 2 myocardial infarction due to supply-demand mismatch. Trends Cardiovasc Med. 2017;27(6):408–417. doi: 10.1016/j.tcm.2017.03.002
- Smilowitz NR, Weiss MC, Mauricio R, et al. Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis. Int J Cardiol. 2016;218:196–201. doi: 10.1016/j.ijcard.2016.05.045
- Kuznetsova OYu, Dubikaitis TA, Frolova EV, et al. he classification of acute myocardial infarction types and the preconditions for its development. Type II myocardial infarction. Russian family doctor. 2017;21(3):5–15. (In Russ.). doi: 10.17816/RFD201735-15
- Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J. 2011;32(4):404–411. doi: 10.1093/eurheartj/ehq456
- Masri W, Le Guillou E, Hamdi E, et al. Troponin elevation in other conditions than acute coronary syndromes. Ann Biol Clin (Paris). 2017;75(4):411–419. doi: 10.1684/abc.2017.1262
- Eggers KM, Lindahl B. application of cardiac troponin in cardiovascular diseases other than acute coronary syndrome. Clin Chem. 2017;63(1):223–235. doi: 10.1373/clinchem.2016.261495
- Sarkisian L, Saaby L, Poulsen TS, et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med. 2016;129(4):446e.5–446e.21. doi: 10.1016/j.amjmed.2015.11.006
- Brinkmann C, Schofer J. 4th universal definition of myocardial infarction 2018: What is new? Herz. 2018;43(8):681–688. doi: 10.1007/s00059-018-4763-6. (In German)
- Chapman AR, Shah ASV, Lee KK, et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation. 2018;137(12):1236–1245. doi: 10.1161/circulationaha.117.031806
- Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med. 2013;126(9):789–797. doi: 10.1016/j.amjmed.2013.02.029
- Stein GY, Herscovici G, Korenfeld R, et al. Type-II myocardial infarction – patient characteristics, management and outcomes. PLoS One. 2014;9(1):e84285. doi: 10.1371/journal.pone.0084285
- Greenslade JH, Adikari T, Mueller C, et al. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study. Emerg Med J. 2018;35(3):169–175. doi: 10.1136/emermed-2017-206869
- McCarthy CP, Murphy S, Cohen JA, et al. Sex differences in patient characteristics, treatment strategies, and outcomes for type 2 myocardial infarction . J Am Coll Cardiol. 2019;(73)24:3230–3233. doi: 10.1016/j.jacc.2019.04.016
- Chapman AR, Adamson PD, Mills NL. Assessment and classification of patients with myocardial injury and infarction in clinical practice. Heart. 2017;103(1):10–18. doi: 10.1136/heartjnl-2016-309530
- Melberg T, Burman R, Dickstein K. The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol. 2010;139(3):228–233. doi: 10.1016/j.ijcard.2008.10.021
- McCarthy CP, Vaduganathan M, Januzzi JL Jr. Type 2 Myocardial infarction-diagnosis, prognosis, and treatment. JAMA. 2018;320(5):433–434. doi: 10.1001/jama.2018.7125
- Zharskiy SL. Type 2 Myocardial Infarction: the current state of the problem. Far East Medical Journal. 2016;3:134–138. (In Russ.)
- Neumann JT, Sörensen NA, Rübsamen N, et al. Discrimination of patients with type 2 myocardial infarction. Eur Heart J. 2017;38(47):3514–3520. doi: 10.1093/eurheartj/ehx457
- Collinson P, Lindahl B. Type 2 myocardial infarction: the chimaera of cardiology? Heart. 2015;101(21):1697–1703. doi: 10.1136/heartjnl-2014-307122
- Spatz ES, Curry LA, Masoudi FA, et al. The variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) classification system: a taxonomy for young women with acute myocardial infarction. Circulation. 2015;132(18):1710–1718. doi: 10.1161/CIRCULATIONAHA.115.016502
- Arora S, Cavender MA, Chang PP. Outcomes of decreasing versus increasing cardiac troponin in patients admitted with non-ST-segment elevation myocardial infarction: the atherosclerosis risk in communities surveillance study. Eur Heart J Acute Cardiovasc Care. 2019:2048872619842983. doi: 10.1177/2048872619842983. Online ahead of print.
- Sandoval Y, Smith SW, Sexter A, et al. Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury. Eur Heart J Acute Cardiovasc Care. 2020;9(1):62–69. doi: 10.1177/2048872618787796
- Kolodgie FD, Virmani R, Finn AV, Romero ME. Embolic myocardial infarction as a consequence of atrial fibrillation: a prevailing disease of the future. Circulation. 2015;132(4):223–226. doi: 10.1161/CIRCULATIONAHA.115.017534
- Sandoval Y, Smith SW, Thordsen SE, Apple FS. Supply/demand type 2 myocardial infarction: should we be paying more attention? J Am Coll Cardiol. 2014;63(20):2079–2087. doi: 10.1016/j.jacc.2014.02.541
- Agewall S, Beltrame JF, Reynolds HR, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017;38(3):143–153. doi: 10.1093/eurheartj/ehw149
- Niccoli G, Scalone G, Crea F. Acutemyocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management. Eur Heart J. 2015;36(8):475–481. doi: 10.1093/eurheartj/ehu469
- Alpert JS, Thygesen KA, White HD, Jaffe AS. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med. 2014;127(2):105–108. doi: 10.1016/j.amjmed.2013.09.031
- Nestelberger T, Boeddinghaus J, Badertscher P, et al. Effect of definition on incidence and prognosis of type 2 myocardial infarction. J Am Coll Cardiol. 2017;70(13):1558–1568. doi: 10.1016/j.jacc.2017.07.774
- Thygesen K, Jaffe AS. Detecting myocardial infarction type 2: targetting the right patients. Eur Heart J. 2017;38(47):3521–3522. doi: 10.1093/eurheartj/ehx557
- Radovanovic D, Pilgrim T, Seifert B, et al. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice. J Cardiovasc Med (Hagerstown). 2017;18(5):341–347. doi: 10.2459/JCM.0000000000000504
- Smilowitz NR, Subramanyam P, Gianos E, et al. Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction. Coron Artery Dis. 2018;29(1):46–52. doi: 10.1097/MCA.0000000000000545
- Cediel G, Sandoval Y, Sexter A, et al. Risk estimation in type 2 myocardial infarction and myocardial injury: the tarraco risk score. Am J Med. 2019;132(2):217–226. doi: 10.1016/j.amjmed.2018.10.022
- Cediel G, Gonzalez-Del-Hoyo M, Carrasquer A, et al. Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury. Heart. 2017;103(8):616–622. doi: 10.1136/heartjnl-2016-310243
- Lambrecht S, Sarkisian L, Saaby L, et al. Different causes of death in patients with myocardial infarction type 1, type 2, and myocardial injury. Am J Med. 2018;131(5):548–554. doi: 10.1016/j.amjmed.2017.11.043